The Kaluga Pharmaceutical Cluster has executed a cooperation agreement with C.H.I.C.O., an Italian major cluster
Kaluga pharma cluster to intensively cooperate with Italy
The Kaluga Pharmaceutical Cluster has executed a cooperation agreement with C.H.I.C.O., an Italian major cluster.
The agreement was signed during the annual Russian-Italy partnering forum called "Meet in Italy for Life Sciences".
The agreement was signed by Irina Novikova, the Executive Director of the Kaluga Pharmaceutical Cluster, on behalf of the Russian party, and by Fabio Miralia, the CEO of C.H.I.C.O. cluster, on behalf of the Italian party.
The executed agreement provides for cooperation in a number of priority areas being ordinary for clusters, such as: technology development and production of original pharmaceutical substances; licensing and production of finished dosage forms; utilization (processing) of pharmaceutical products.
The agreement will be implemented, among other things, through the exchange of best practices and participation in joint economic development projects.
C.H.I.CO. (Cluster of Health, Innovation and Community), the first healthcare cluster of Lazio (Italy) and a non-profit organization devoted to life science and healthcare uniting about 100 members.
The Russian Direct Investment Fund (RDIF) together with partners from Saudi Arabia intend to invest $2 bln in technology projects in 2019, head of RDIF Kirill Dmitriev said...
Russian business aims to expand the zone of realization of goods in China, not settling for the traditional area of marketing in its northern and northeastern parts.
The State Duma of Russia adopted the law on ratification of the agreement between Russia and Turkmenistan on strategic partnership.
About the models of business development in another country and professional secrets is told by a practicing expert on work in international markets Anna Trubetskaya